Posology and second prescription: dose, repetition, and review judgment

Posology is the study of dose — potency selection, dose quantity, repetition timing — and second prescription is the decision made at review: wait, repeat, change potency, or change remedy. Together they constitute the half of prescribing that remedy knowledge alone never covers. First prescriptions get the attention; second prescriptions decide the outcomes. This guide (companion to the potency guideline) trains review judgment systematically.

The five review outcomes

Cure: complaint resolves with generals improving — close the episode, keep the diary. Continuing improvement: trajectory favourable but incomplete — wait without repetition, the commonest correct and most-skipped decision. Stall after gain: improvement plateaus in the same picture — consider repetition or potency step under practitioner rules. Partial or sideways movement: some lines improve, others don’t, or the picture shifts — re-take concomitants and modalities before acting. No action: nothing moves after adequate window — re-take the whole case including remedy choice, potency, and staging. Aggravation or red flags: hold or escalate medically per the aggravation guide. Naming the outcome aloud before acting prevents the default reflex (repeat something, anything) that ruins most follow-ups.

Review windows that discipline judgment

Acute intense: hours. Subacute: 1–3 days. Recent mild chronic: 2–4 weeks. Entrenched constitutional: 4–8 weeks. Windows are agreed before dosing, with the patient instructed what to log and which exits override the calendar. A review without pre-agreed criteria degenerates into impression management; a review with them is a measurement. Record the outcome classification verbatim in the diary — series of classifications across months reveal prescriber patterns (chronic repeaters, potency escalators, remedy hoppers) worth confronting.

Remedy relationships: the sequencing grammar

Complementary remedies follow well (the classical Belladonna–Calcarea-type sequences): improvement opens a new layer the complement covers. Antidotal relationships moderate overshooting per traditional lore — modern practice prefers waiting and reassessment first. Inimical pairs ( remedies traditionally ill-following each other) warn against specific sequences. Concordances and families (botanical, mineral-row, miasmatic groupings) suggest neighbours when the first choice stalls laterally. Relationships suggest; reassessment decides — no sequence runs on autopilot, and every switch needs fresh totality evidence.

Obstacles to cure: the pre-potency checklist

Before raising potency or switching remedies in stalled chronic work, audit: sleep quantity and apnoea signs; medication and supplement load with timings; stimulant and alcohol load; occupational and dental maintaining causes; unaddressed pathology needing medical management; and case-taking gaps (thin modalities, missing concomitants). The majority of “difficult cases” resolve at this checklist stage — posology cannot compensate for management gaps, and the checklist is where senior prescribers spend the time juniors spend choosing between 200C and 1M.

LM management in outline

Daily adjustable dosing from LM1 with succussion-count titration, dilution staging, and 1–4 week reviews — exclusively practitioner territory. The method’s power is adjustability to sensitivity; its discipline is the log (daily one-liners on sleep, chief symptom, energy, new symptoms) without which titration is blind. Never improvise daily schedules from internet fragments: untitrated repetition is precisely what LM method was designed to replace.

Teaching second prescription

Supervisors drill it with stalled-case conferences: present the diary, classify the outcome blind (without revealing what was done), commit to wait/repeat/change with reasons, then compare against the actual course. Three habits mark competence: comfort with waiting, specificity about repetition criteria, and eagerness to re-take rather than escalate. Students should track their own outcome distribution across fifty cases — the shape of the distribution diagnoses the prescriber.

Frequently asked questions

What is the single commonest second-prescription error?

Repeating into steady improvement — interrupting a cure to “help it along.” When in doubt between waiting and repeating, waiting wins the statistics.

When is changing remedy right?

Changed picture with fresh totality pointing elsewhere, or two well-matched doses with zero movement. Both need documented evidence, not restlessness.

How do complementary remedies actually work in sequence?

First remedy resolves its layer, revealing a distinct totality the complement matches; each step is independently verified, never assumed from relationship tables alone.

What records make review possible?

Dated baselines, dose details (remedy, potency, method, manufacturer), scheduled windows, outcome classifications, and obstacle audits — the five-line review record.

Study checklist

• Classify your last five follow-ups into the six outcomes with written reasons.
• State one complementary, one inimical, and one antidotal relationship with its traditional rationale.
• Run the obstacle checklist on your most stalled case before any potency decision.
• Read Organon §§246–294 alongside your diary’s repetition entries.

Original pillar guide for ItsHomeopathy. Read with the potency guideline and aggravation guide; supervised training cases recommended.

Two worked reviews

Review 1 — the correct wait: single dose for a clear chronic picture; week three brings steady sleep improvement with the chief complaint at 70%, week five at 85% and still moving. The itch to “finish it off” with repetition is strong — and wrong: outcome classification is continuing improvement, action is waiting with the next review booked. Month three closes the episode. Diaries of such waits, reread yearly, teach more posology than any chapter on potency selection.

Review 2 — the honest switch: two well-matched doses across six weeks move nothing; modalities re-taken reveal the thermal line was assumed, never asked — patient is warm-blooded, remedy chilly throughout. Classification: no action, wrong match; action: re-take fully and switch on fresh totality evidence. The failure converts to method gold the moment its mechanism (assumed generals) is named in the diary’s lessons column.

Three comparisons that teach

Waiting versus repeating: waiting risks nothing but time when trajectory favours; repeating risks proving pictures, aggravation noise, and destroyed baselines. The asymmetry favours waiting far more often than impatience admits — make impatience justify itself in writing before every repetition.

Potency change versus remedy change: same picture stalled after real gain suggests potency/posology review; shifted or never-matching pictures demand remedy review. Escalating potency against a wrong remedy is the most expensive common error in chronic work — it spends aggravation risk while the match stays wrong.

Complementary sequence versus remedy hopping: sequences follow verified layer emergence with fresh totalities; hopping follows restlessness across unverified guesses. The diary distinguishes them: sequences cite lines, hopping cites hopes.

Timeline and self-examination

Organon §§246–294 observation rules → Kentian follow-up classification → contemporary second-prescription systematics → LM-era titration discipline → modern obstacle-audit integration. Self-exam: (1) classify your last ten follow-ups into the six outcomes with diary quotes; (2) compute your wait/repeat/switch distribution and compare against a teacher’s; (3) run the obstacle checklist on your most stalled case before any further posology decision — and record what it found.

Answering skeptics and confused students

“Isn’t ‘wait and see’ just doing nothing billably?” Structured waiting — with windows, logs, exits, and pre-agreed criteria — is active management with the lowest intervention cost. Unstructured waiting without criteria deserves the charge; never confuse the two, and never pay indefinitely for either without outcome review.

“Why not just re-dose at every visit?” Because repetition without relapse-after-gain adds noise, risks proving overlays, and destroys the baseline readability the next decision needs. Each unnecessary dose mortgages future clarity for present busyness.

“When is switching practitioners justified?” When reviews lack classifications, repetitions lack criteria, obstacles go unaudited across months, or outcomes plateau without strategy change — and the new practitioner should receive your full diary, including the disagreements.

Ten-question self-test (with answers)

1. Six review outcomes? Cure, continuing improvement, stall-after-gain, partial/sideways, no action, aggravation/red-flags — named aloud before acting.

2. Commonest correct skipped decision? Waiting through continuing improvement — repetition into running cures ruins baselines.

3. Windows? Hours acute, 1–3 days subacute, 2–4 weeks recent chronic, 4–8 constitutional — agreed before dosing with exits overriding.

4. Complementary versus hopping? Verified layer emergence with fresh totalities versus restlessness across guesses — diaries distinguish them.

5. Before raising potency, audit? Sleep/apnoea, medicines/supplements, stimulants, occupational/dental causes, pathology gaps, case-taking thinness.

6. LM’s core discipline? Daily one-line logs enabling succussion-count titration — adjustability without records is improvisation.

7. Potency-versus-remedy fork? Same-picture stall suggests posology review; shifted/never-matching pictures demand remedy review.

8. Impatience’s cost accounting? Proving overlays, aggravation noise, destroyed baselines mortgaging future clarity — make haste justify itself in writing.

9. Competence metrics? lengthening waits without anxiety, repetition criteria specificity, re-take eagerness, outcome-distribution shape across fifty cases.

10. Justified switching? Documented changed picture or two well-matched motionless doses — plus full diary handover including disagreements.

Three passages to read firsthand

Organon §§246–294 — observation rules primary-sourced with commentary. Your own repetition entries versus outcomes — the personal trial data no book contains. A teacher’s stalled-case conference notes — blind classification practice against disclosed courses.

Ten review drills (with answers)

1. “85% better, still moving, week five”: continuing improvement — wait, review booked, no repetition.

2. “Gained to 60% by week two, static since”: stall-after-gain, same picture — repetition-or-potency review per rules.

3. “Headache gone, rash appeared, sleep great”: direction-of-cure pattern — hold, observe, welcome cautiously with dermatology awareness.

4. “Partial shift: pain less, new anxiety”: sideways movement — re-take concomitants before any action.

5. “Nothing at six weeks, two good doses”: no action — full re-take including remedy, potency, staging, obstacles.

6. “Brief flare day one, steady gains since”: classical aggravation resolved — diary-graded hold vindicated.

7. “Better only on dose days, fading between”: palliative pattern — depth/layer review, obstacle audit, strategy rethink.

8. “New picture, clearly different totality”: fresh prescription on fresh evidence — relationship tables suggest, totality decides.

9. “Wants to switch after ten days of movement”: impatience, not indication — show the trajectory graph, hold the plan.

10. “Red-flag feature week three”: medicine first, posology parked — state timeline plainly to clinicians, resume method only after clearance.

The fifty-case outcome journal: setup and use

Columns: date, case identifier, presentation one-liner, remedy/potency/method, pre-agreed window and exits, outcome classification at review, next action with reason. After fifty entries, compute: wait rate (target high in continuing improvement), repeat rate with relapse-after-gain evidence attached, switch rate with fresh-totality citations, escalation rate with obstacle-audit completion. Compare distributions with a teacher’s; the gaps name your training edges precisely (chronic repeaters repeat, potency escalators escalate, hoppers hop — the journal makes style visible). Review the journal quarterly, retire one bad habit per quarter, and watch outcome distributions move before remedy knowledge expands at all — because at fifty cases, method outweighs materia medica in explaining results.

Supervision: getting it and using it

Bring diaries, not narratives: dated baselines, dose details, window agreements, classifications attempted. Ask supervisors to classify blind before revealing your action, then dissect divergences line by line — the discomfort is the tuition. Present failures preferentially; successes teach little and flatter much. Between sessions, run the obstacle checklist and the six-outcome drill on every open case so supervision time goes to judgment edges rather than data gathering. One supervised stalled case dissected thoroughly advances second-prescription skill more than ten smooth ones summarised.

Seven supervision questions to ask with every stalled case

1. “Show me the dated baselines.” No baselines, no classification — restore logging before any decision.

2. “What was pre-agreed for this window?” Post-hoc criteria are rationalisation; only pre-commitments count.

3. “Which outcome class, with quotes?” Diary evidence attached to cure/stall/drift/no-action claims, or the claim waits.

4. “What obstacles were audited, when?” Sleep, medicines, exposures, pathology gaps — unchecked boxes decide before potencies do.

5. “What would falsify the current remedy?” Pre-stated falsifiers convert loyalty into method; absence of any reveals attachment.

6. “What did the last three similar cases teach?” Pattern across your own outcomes beats textbook generalities for personal calibration.

7. “What happens if we simply wait a month?” The null plan, costed honestly — often the best plan available, and naming it prevents disguised drift.

The quarterly self-audit (worked format)

Pull all closed episodes from the quarter and tabulate outcome classes with counts: cures, continuing-improvement waits honoured versus broken, stall-after-gain repetitions with evidence attached, remedy switches with fresh-totality citations, escalations with obstacle audits completed. Compute three ratios: waiting discipline (waits honoured over waits indicated), evidence density (decisions with diary quotes over total decisions), and audit completion (escalations with checklists over total escalations). Set one numeric target for next quarter against your weakest ratio — single-target quarters outperform resolution lists. File the audit beside the fifty-case journal; together they constitute the only posology examination that matters, administered by your own outcomes to your own habits, every ninety days without exception.